We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
116 hedge funds and large institutions have $102M invested in Cardiff Oncology in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
226% more call options, than puts
Call options by funds: $3.03M | Put options by funds: $929K
194% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 17
6.39% more ownership
Funds ownership: 42.23% → 48.62% (+6.4%)
1% less funds holding
Funds holding: 117 → 116 (-1)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
17% less capital invested
Capital invested by funds: $122M → $102M (-$20.4M)
Holders
116
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
50
Reduced
17
Closed
17
Calls
$3.03M
Puts
$929K
Net Calls
+$2.1M
Net Calls Change
-$1.23M
Top Buyers
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$5.81M |
| 2 |
BlackRock
New York
|
+$3.96M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.28M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.72M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.63M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$3.81M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.21M |
| 3 |
Renaissance Technologies
New York
|
-$2.1M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.95M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$778K |
